To test this, we investigated the effect of pharmacological CK2 inhibition with CX-4945 as well as CK2α knockout (KO) on NG2 expression, cell proliferation and migration in human NG2-positive GBM cell lines. This evidence concerns the gene CSPG4 and glioblastoma.